Adin Ermie
Colorado-based, Enveda Biosciences is a bio-tech company that uses AI to translate medicines raised $55 million led by Premji Invest in additional funding.
After this additional funding the total amounts raised is $119 million. The round was backed by new and existing investors include The Nature Conservancy, Microsoft, and Lingotto Investment Funds.
True Ventures, Kinnevik, Jazz Venture Partners, Level Ventures, and FPV also backed the round. A total amount of 230 million is raised till the closing of B2 Series.
CEO Enveda Biosciences, Dr. Viswa Colluru said that the amount raised will enable us for the product development.